Back
Science

SMEAR-ULM technology detects early-stage melanoma via temperature variations

View source

Our goal is to provide a minimally invasive tool to detect very small, but still aggressive melanomas.
— Jinyang Liang, senior author

New 'Intelligent Tattoo' Detects Melanoma Before It's Visible

Researchers from INRS and Université de Montréal have developed a groundbreaking system, dubbed SMEAR-ULM, that can detect melanoma by measuring subtle temperature variations on the skin. In mouse models, the system identified micro-melanomas as early as four days old—long before they are visible or detectable by conventional imaging.

How It Works

The technology employs a microneedle patch to deposit nanoparticles under the skin, creating a temporary 'intelligent tattoo.' When illuminated with near-infrared light, these nanoparticles emit visible light. Critically, the lifetime of that emitted light depends directly on the local temperature.

An ultrafast imaging system then captures a single high-speed snapshot to generate a detailed thermal map. This map boasts submillimeter spatial resolution and sub-degree temperature sensitivity.

A Major Leap Over Current Methods

The impact is significant. Conventional thermal imaging typically can only detect tumors larger than 5 mm. The SMEAR-ULM system, by contrast, can catch aggressive melanomas at a much earlier, smaller stage.

First author Yingming Lai explained the technical breakthrough: "We capture all the necessary information for an instantaneous temperature map in a single shot, which makes the method fast and robust."

Applications and Future Potential

This technology holds promise for multiple clinical benefits:

  • Reducing unnecessary biopsies by providing clearer early evidence of malignancy.
  • Improving early diagnosis of aggressive skin cancers.
  • Supporting clinical decision-making with high-resolution data.

Researchers also note that the platform itself could be adapted to map other physiological parameters, such as pH or ion concentrations.

Co-principal author Sylvain Meloche cautioned that while the study was conducted in mice, the model used "replicates genetic changes observed in human melanomas," suggesting strong translational potential.